Skip to content
Riskpilot
← Back to search
Sign in
Get full access
CD Pharmaceuticals AB
AB
Active
Org 5568002322
Ulls Väg 29 A, 756 51
Uppsala
Leasing of intellectual property and similar products, except copyrighted works
·
NACE 7740
Est. 2010 · 16 years old
2 employees
Monitor
Share
Sweden
/
Companies
/
Leasing of intellectual property and similar products, except copyrighted works
/
CD Pharmaceuticals AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
12M
23M
35M
46M
6M
2020
16M
2021
36M
2022
38M
2023
40M
2024
EBITDA
SEK millions
14M
10M
6M
2M
-3M
-2M
2020
4M
+300%
2021
11M
+175%
2022
8M
-27%
2023
6M
-25%
2024
Income statement
SEK thousands
Item
2020
2021
2022
2023
2024
Revenue
6 179
15 503
36 196
38 136
40 458
Staff expenses
—
—
—
—
—
EBITDA
−1 595
4 012
10 847
7 505
5 943
Depreciation & amort.
−0
−0
−0
−0
−895
EBIT
−1 595
4 012
10 847
7 505
5 048
Net financials
940
−807
−1 836
−7
328
Profit before tax
2
2 402
6 758
5 697
4 376
Tax
−1
−497
−1 394
−1 194
−944
Net profit
1
1 905
5 364
4 503
3 432
Balance sheet
SEK thousands
Item
2020
2021
2022
2023
2024
Total assets
21 907
27 807
23 185
33 027
35 154
Equity
2 234
4 139
9 503
14 006
17 438
Long-term debt
0
0
0
0
0
Short-term debt
19 409
22 600
10 362
13 900
11 596
Total debt
19 409
22 600
10 362
13 900
11 596
Financial ratios
5-year trend
EBITDA margin
14.7%
This company
15.8%
Market median
-7% vs market
2020
2024
Equity ratio
49.6%
This company
38.2%
Market median
+30% vs market
2020
2024
Return on equity
19.7%
This company
18.4%
Market median
+7% vs market
2020
2024
Net profit margin
8.5%
This company
8.1%
Market median
+5% vs market
2020
2024
Asset turnover
1.15×
This company
1.12×
Market median
+3% vs market
2020
2024
Debt / equity
1.02×
This company
0.62×
Market median
-65% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-07-01 – 2020-12-31
View
PDF
More on CD Pharmaceuticals AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
